TERT and cancer: However, in cancer cells the tight control of TERT transcription is disrupted by the aberrant expression of TERT promoter activators, primarily MYC, and by nuclear factor kappa B (NF-κB) signaling that is considered the master regulator of TERT activation in cancer cells [23].